Faster cyclic loess: Normalizing RNA arrays via linear models

Mayo Clinic - Rochester, Рочестер, Minnesota, United States
Bioinformatics (Impact Factor: 4.98). 12/2004; 20(16):2778-86. DOI: 10.1093/bioinformatics/bth327
Source: PubMed


Our goal was to develop a normalization technique that yields results similar to cyclic loess normalization and with speed comparable to quantile normalization.
Fastlo yields normalized values similar to cyclic loess and quantile normalization and is fast; it is at least an order of magnitude faster than cyclic loess and approaches the speed of quantile normalization. Furthermore, fastlo is more versatile than both cyclic loess and quantile normalization because it is model-based.
The Splus/R function for fastlo normalization is available from the authors.

Full-text preview

Available from:
  • Source
    • "Taking into account that ComBat does not eliminate batch effect with the conditions of our dataset, we decided to partially solve this issue as follows: After preprocessing all arrays with frma (McCall et al., 2010), and using summarization with robust weighted average with no background correction, we split the datasets into cases/controls, and then applied ComBat to both datasets separately. After that, we re-joined the two resulting datasets and re-normalized them together with the cyclic loess algorithm (Ballman et al., 2004), in such way that both conditions belong now to the same dynamic range We needed to have a measure of the batch effect within the samples so that we could remove the corresponding bias as accurately as possible. To this end we resort to Principal Variance Component Analysis (PVCA) that is an algorithm that combines the advantages of the principal component analysis (reduction of dimensionality) with the components of the analysis of variance (Grass, 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gene regulatory networks account for the delicate mechanisms that control gene expression. Under certain circumstances, gene regulatory programs may give rise to amplification cascades. Such transcriptional cascades are events in which activation of key-responsive transcription factors called master regulators trigger a series of gene expression events. The action of transcriptional master regulators is then important for the establishment of certain programs like cell development and differentiation. However, such cascades have also been related with the onset and maintenance of cancer phenotypes. Here we present a systematic implementation of a series of algorithms aimed at the inference of a gene regulatory network and analysis of transcriptional master regulators in the context of primary breast cancer cells. Such studies were performed in a highly curated database of 880 microarray gene expression experiments on biopsy-captured tissue corresponding to primary breast cancer and healthy controls. Biological function and biochemical pathway enrichment analyses were also performed to study the role that the processes controlled - at the transcriptional level - by such master regulators may have in relation to primary breast cancer. We found that transcription factors such as AGTR2, ZNF132, TFDP3 and others are master regulators in this gene regulatory network. Sets of genes controlled by these regulators are involved in processes that are well-known hallmarks of cancer. This kind of analyses may help to understand the most upstream events in the development of phenotypes, in particular, those regarding cancer biology.
    Full-text · Article · Sep 2015 · Computational biology and chemistry
  • Source
    • "Analyses for both data types were performed on the log base 2 scale. For each data type, all samples were normalized together as study groups should not have wholesale changes in RNA concentration using appropriate model-based algorithms (Ballman et al. 2004; Oberg et al. 2008). Data were analyzed using linear models (ANOVA models) (Kerr et al. 2000; Wolfinger et al. 2001; Hill et al. 2008; Oberg et al. 2008; Oberg and Vitek 2009) together with empirical Bayes methods (Smyth 2004), which are appropriate for mitigating the risk of false discovery in small sample sizes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Adenosine signaling has been implicated in several neurological and psychiatric disorders. Previously, we found that astrocytic excitatory amino acid transporter 2 (EAAT2) and aquaporin 4 (AQP4) are downregulated in the striatum of mice lacking type 1 equilibrative nucleoside transporter (ENT1).Methods To further investigate the gene expression profile in the striatum, we preformed Illumina Mouse Whole Genome BeadChip microarray analysis of the caudate–putamen (CPu) and nucleus accumbens (NAc) in ENT1 null mice. Gene expression was validated by RT-PCR, Western blot, and immunofluorescence. Using transgenic mice expressing enhanced green fluorescence protein (EGFP) under the control of the glial fibrillary acidic protein (GFAP) promoter, we examined EGFP expression in an ENT1 null background.ResultsGlial fibrillary acidic protein was identified as a top candidate gene that was reduced in ENT1 null mice compared to wild-type littermates. Furthermore, EGFP expression was significantly reduced in GFAP-EGFP transgenic mice in an ENT1 null background in both the CPu and NAc. Finally, pharmacological inhibition or siRNA knockdown of ENT1 in cultured astrocytes also reduced GFAP mRNA levels.Conclusions Overall, our findings demonstrate that ENT1 regulates GFAP expression and possibly astrocyte function.
    Full-text · Article · Nov 2014 · Brain and Behavior
  • Source
    • "Data quality was assessed via box and whisker plots along with residual and pair-wise MVA plots before and after normalization [29,30]. All arrays were normalized together using fastlo, a non-linear normalization similar to cyclic loess which runs in a fraction of the time [31]. Both supervised and unsupervised analyses were performed. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background Loss of the endosulfatase HSulf-1 is common in ovarian cancer, upregulates heparin binding growth factor signaling and potentiates tumorigenesis and angiogenesis. However, metabolic differences between isogenic cells with and without HSulf-1 have not been characterized upon HSulf-1 suppression in vitro. Since growth factor signaling is closely tied to metabolic alterations, we determined the extent to which HSulf-1 loss affects cancer cell metabolism. Results Ingenuity pathway analysis of gene expression in HSulf-1 shRNA-silenced cells (Sh1 and Sh2 cells) compared to non-targeted control shRNA cells (NTC cells) and subsequent Kyoto Encyclopedia of Genes and Genomics (KEGG) database analysis showed altered metabolic pathways with changes in the lipid metabolism as one of the major pathways altered inSh1 and 2 cells. Untargeted global metabolomic profiling in these isogenic cell lines identified approximately 338 metabolites using GC/MS and LC/MS/MS platforms. Knockdown of HSulf-1 in OV202 cells induced significant changes in 156 metabolites associated with several metabolic pathways including amino acid, lipids, and nucleotides. Loss of HSulf-1 promoted overall fatty acid synthesis leading to enhance the metabolite levels of long chain, branched, and essential fatty acids along with sphingolipids. Furthermore, HSulf-1 loss induced the expression of lipogenic genes including FASN, SREBF1, PPARγ, and PLA2G3 stimulated lipid droplet accumulation. Conversely, re-expression of HSulf-1 in Sh1 cells reduced the lipid droplet formation. Additionally, HSulf-1 also enhanced CPT1A and fatty acid oxidation and augmented the protein expression of key lipolytic enzymes such as MAGL, DAGLA, HSL, and ASCL1. Overall, these findings suggest that loss of HSulf-1 by concomitantly enhancing fatty acid synthesis and oxidation confers a lipogenic phenotype leading to the metabolic alterations associated with the progression of ovarian cancer. Conclusions Taken together, these findings demonstrate that loss of HSulf-1 potentially contributes to the metabolic alterations associated with the progression of ovarian pathogenesis, specifically impacting the lipogenic phenotype of ovarian cancer cells that can be therapeutically targeted.
    Full-text · Article · Aug 2014
Show more